Angiotensin-converting enzyme inhibitors were associated with an increased risk of stroke outcomes (11% increased risk of combined fatal and nonfatal hospitalized stroke) compared with diuretics, and this effect persisted well beyond the trial period. The gene discussed is ACE; the disease is stroke disorder.